Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Augusta University
Augusta University
Chulalongkorn University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Institute of Hematology & Blood Diseases Hospital, China
Memorial Sloan Kettering Cancer Center
Wondercel Biotech (ShenZhen)
Institute of Hematology & Blood Diseases Hospital, China
Shenzhen Genocury Biotech Co., Ltd.
Institute of Hematology & Blood Diseases Hospital, China
Peking University First Hospital
Icahn School of Medicine at Mount Sinai
The First Affiliated Hospital with Nanjing Medical University
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Affiliated Hospital of Jiangsu University
Peking University First Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Hrain Biotechnology Co., Ltd.
Oncotherapeutics
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Changzheng Hospital
Shanghai Changzheng Hospital
Changzhou No.2 People's Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Case Comprehensive Cancer Center
Guangdong Second Provincial General Hospital
Shanghai Changzheng Hospital
Nanexa AB
Hebei Senlang Biotechnology Inc., Ltd.
First Affiliated Hospital of Fujian Medical University
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Affiliated Hospital of Jiangnan University
Shenzhen Pregene Biopharma Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Zhejiang University
Beijing Immunochina Medical Science & Technology Co., Ltd.
Zhejiang University
Zhejiang University
Peking Union Medical College Hospital
Xinqiao Hospital of Chongqing
Zhejiang University
Shanghai Changzheng Hospital
Northwestern University
Hrain Biotechnology Co., Ltd.
Shanghai Changzheng Hospital
Zhejiang University
Zhejiang University
PersonGen BioTherapeutics (Suzhou) Co., Ltd.